The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure

Journal of Internal Medicine

Volumn 243, Issue 2, 1998, Pages 93-98

  Samsonov, M ^a   Lopatin, J ^a   Tilz, G P ^b   Artner Dworzak, E ^c   Nassonov, E ^a   Mareev, V ^a   Belenkov, J ^a   Wachter, H ^c   Fuchs, D ^c  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Aldosterone; Angiotensin; Congestive heart failure; Immune activation; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CYTOKINE RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 2 RECEPTOR; NEOPTERIN; RENIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CACHEXIA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WEIGHT REDUCTION;

EID: 0031960810     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00240.x     Document Type: Article

References (34)

1. Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. N Engl J Med 1994; 330: 1129-35.
2. Samsonov M, Nassonov E, Wachter H, Fuchs D. Heart disease and immune system activation. Eur J Intern Med 1993; 4: 267-80.
3. Hwang S, Harris TJ, Wilson NW, Maisel AS. Immune function in patients with chronic stable congestive heart failure. Am Heart J 1993; 125: 1651-57.
4. Pye M, Rae AR, Cobbe SM. Study of serum C-reactive protein concentration in cardiac failure. BR Heart J 1990; 63: 228-30.
5. Fuchs D, Samsonov M, Tilz GP, Reibnegger G, Belenkov J, Nassonov E et al. Stimulated cellular immune system in patients with congestive heart failure. Eur J Clin Chem Biochem 1993; 31: 111-14.
6. Samsonov M, Fuchs D, Reibnegger G, Belenkov J, Nassonov E, Wachter H. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis. Clin Chem 1992; 38: 678-80.
7. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994, 90: 556-73.
8. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure AM J Pathol 1996; 148: 141-9.
9. Katz AM. Cell death in the Failing heart: role of an unnatural growth response to overload. Clin Cardiol 1995; 18 (Suppl 4): 36-44.
10. Sole MJ, Schimmer J, Golstein D, Li R-K. Oxidative stress contributes to decompensation of the failing heart. Circulation 1995; 92 (Suppl 1): 1-31 (abstract).
11. Irwin M, Qu R, Chiamvimonvat V, Aitken K, Mak S, Dawood F, et al. The relationship between tumour necrosis factor-alpha and myocyte apoptosis and necrosis: in vivo and in vitro evidence. Circulation 1996; 94 (Suppl.): 1-32 (abstract).
12. Fuchs D, Baier-Bitterlich G, Wede I, Wachter H. Reactive oxygen and apoptosis. In: Scandalios J, ed. Oxidative Stress and the Molecular Biology of Antioxidant Defenses. New York, USA: Cold Spring Harbor Laboratories Press, 1997, 139-67.
13. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Enal J Med 1990; 323: 236-41.
14. McMurray J, Abdallah I, Dargie HJ, Shapiro. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991; 66: 356-8.
15. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A et al. Tumour necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-86.
16. Packer M. Is tumour necrosis factor important neurohormonal mechanism in chronic heart failure? Circulation 1995; 92: 1379-82.
17. Antonipillai YW, Wang Y, Horton R. Tumour necrosis factor and interleukin-1 may regulate renin secretion. Endocrinology 1990; 126: 273-8.
18. Simon MR, Engel DE, Weinstok JV. Angiotensin II supression of human mononuclear cell reactivity is associated with enhanced OKT84+ lymphocyte thymidine incorporation. J Immunopharmacol 1986; 8: 289-97.
19. Samsonov M, Tilz GP, Pisklakov V, Reibnegger G, Nassonova V, Wachter H et al. Serum-soluble receptors for tumour necrosis factor-α and inlerleukin-2. and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 1995; 74: 31-4.
20. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113: 619-27.
21. Packer M. Pathophysiology of chronic heart failure. Lancet 1992; 340: 88-92.
22. Epstein F. Mechanisms of disease. Neuroendocrine-immune interactions, N Engl J Med 1993; 329: 1246-53.
23. Samsonov M, Nassonov E, Tilz GP, Werner-Felmayer G, Artner-Dworzak E, Wachter H et al. Association between the renin-angiotensin system and immune activation in vitro and in vivo. Pteridines 1995; 6: 31 (abstract).
24. Fuchs D, Hausen H, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as marker for activated cell-mediated immunity: application in HIV infection, Immunol Today 1988; 9: 150-55.
25. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D, Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1-8.
26. Homolka J, Lorenz J, Zuchold HD, Müller-Quernheim J. Evaluation of soluble CD14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis. Clin Investig 1992; 70: 909-16.
27. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumour necrosis factor-α in conscious dogs. J Clin Invest 1992; 90: 389-98.
28. Murray DR, Freeman GL. Tumour necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996; 78: 154-60.
29. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumour nercosis factor receptors in human myocardium. Circulation 1995; 92: 1487-93.
30. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of the left ventricular dysfunction (SOLVD). JACC 1996; 27: 1201-6.
31. Natarajan R, Ploszaj S, Horton R, Nadler J. Tumour necrosis factor and interleukin-1 are potent inhibitors of angiotensin-II-induced aldosterone synthesis. Endocrinology 1989; 125: 3084-9.
32. Brilla CG, Maisch B, Zhou G, Weber KT. Hormonal regulation of cardiac fibroblast function. Eur Heart J 1995; 16 (Suppl. C): 45-50.
33. Samsonov M, Wachter H, Fuchs D. Serum soluble interleukin-2 receptor, neopterin levels and severity of dilated cardiomyopathy. Circulation 1996; 93: 1255-6.
34. Schobersberger W, Hoffmann G, Hobisch-Hagen P, Boeck G, Voelkl H, Baier-Bitterlich G et al. Neopterin and. 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett 1996; 397: 263-8.